Printer Friendly

European Market For Catheters And Guidewires For Angioplasty And Angiography Report Provides A Detailed Analysis Of The Market.

DUBLIN, Ireland -- Research and Markets ( has announced the addition of the new Frost & Sullivan "European Markets for Catheters and Guidewires for Angioplasty and Angiography" to their offering.

This Frost & Sullivan research service entitled European Market for Catheters and Guidewires for Angioplasty and Angiography provides a detailed analysis of the market. This includes an outlook on the consolidations that could take place as well as an analysis of the major challenges faced by market participants. It also covers key drivers, restraints and geographic trends that are influencing the market. In this research service, Frost & Sullivan's expert analysts thoroughly examine the following markets: catheters and guidewires for angioplasty and angiography.

Manufacturers of Catheters and Guidewires Need to Continuously Innovate to Overcome Potential Threats from Drug Therapies

Changing demographics owing to an ageing population increasingly prone to cardiac diseases and a growing acceptance of minimally invasive surgeries have seen a rise in the number of angiography and angioplasty procedures performed in Europe. This, in turn, drives continued demand for catheters and guidewires that are an integral part of such procedures. Angioplasty catheters contribute the major share of this growing market, which is experiencing considerable innovation and technology development. However, ongoing pharmaceutical developments such as drug therapies that can pre-treat conditions and require catheter intervention only in the later stages could pose a threat to the catheters and guidewires market. Such therapies could also prove to be less expensive than invasive treatments using catheters.

"Despite the development of many new alternative technologies, catheter angioplasty and angiography have a strong hold in the market due to their simple and effective treatment methods," says the analyst of this research service. "As the body part treated is sensitive, minimal invasiveness and effectiveness are of prime importance." This is compelling catheter and guidewire manufacturers to develop products that offer similar features and benefits to those of drug therapies. Some success has already been achieved in this respect with the development of catheters with guidewires attached and angiography catheters that offer multi-purpose usage.

Companies Need to Adopt Novel Strategies to Grow Market Share

Angioplasty catheters account for the major part of the total market's revenues and are growing at a fairly stable rate. On the other hand, the angiography catheters market is growing at a slower place, while the guidewires market is experiencing the highest growth rate, perhaps due to the constant introduction of new technologies.

Market participants need to adopt innovative strategies such as product bundling to increase sales of products that currently have small markets. For instance, manufacturers could look at bundling the sales of guidewires with catheters, which have the advantage of larger markets. Moreover, there have been numerous mergers and acquisitions in the market in recent years, which have resulted in a few major participants holding the bulk of market share. "Thus, a company manufacturing catheters for angioplasty could have a strategic alliance with another that manufactures guidewires," remarks the analyst. "This would not only help manufacturers in increasing their market revenue, but also simplify the purchasing process for hospitals purchasing different products from different companies."

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

-Catheters for angioplasty

-Catheters for angiography



The following technologies are covered in this research:

Balloon Catheters: Balloon catheter is one of the most commonly-used catheters. It has a balloon on the tip. The catheter is passed into the artery and the balloon is pushed against the plaque in the wall, thus flattening it and widening the artery. There are different types of balloon catheters but the most commonly used are as follows: rapid exchange, over the wire, fixed wire and perfusion catheters.

Laser Catheters: A catheter is passed though the blood vessel to reach the blockage and then a laser tip is inserted. The laser tip essentially melts the plaque into gaseous and microscopic particles. Photo-ablation is the process where energy photons cause molecular bond disruption without any thermal damage to the surrounding tissue. The ultra violet energy at the tip is used to photo-ablate the plaques.

Atherectomy Catheters: Atherectomy catheters help in the removal of plaque unlike other catheters, which help in widening blood vessels only. There are different types of atherectomy catheters based on the device fixed to the catheter tip such as the rotating burr tip.

Angiography Catheters: These catheters are used to help in proper visualisation of blood vessel blockages. There are different types of catheters like flush catheters, access catheters and many others.

Guidewires: Guidewires are flexible tubes positioned in a blood vessel for the purpose of directing the catheter. They are used for both angioplasty and angiography, though there are differences in guidewire uses. Guidewires used for angiography are larger and more rigid in comparison to angioplasty guidewires. There are different types of guidewires such as steerable, hydrophilic, teflon-coated, heparin-coated guidewires and many others.

Topics Covered:

-Market Overview

-Market Dynamics

-European Markets for Catheters and Guidewires for Angioplasty and Angiography

-European Markets for Catheters and Guidewires for Angioplasty and Angiography

-European Markets for Catheters and Guidewires for Angioplasty and Angiography

-Strategic Recommendations

-Database of Key Industry Participants

-Decision Support Database

For more information, visit
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Industry overview
Date:Jan 24, 2007
Previous Article:Regency Hospital Company Supports LTAC Hospital Legislation Introduced in U.S. House and U.S. Senate.
Next Article:Jupitermedia Announces Winners of Excellence in Technology Awards.

Related Articles
Angioplasty deemed unnecessary for many.
Rapid X ray opens window to arteries.
Brain angioplasty may prevent strokes.
Success clearing clogged arteries.
Diabetes drug protects reopened heart vessels. (Double Duty).
The three R's: radiation for restenotic renals?
The Chinese and Mexican Market for Stone Management Endourological Disposables was Valued at nearly $15 million in 2005.
Minimally Invasive Procedures Combined with Better Imaging Technologies Boosts Angioplasty and VCD Markets - U.S. Angioplasty and Vascular Closure...
Belated angioplasty saves no lives.
Canadian Peripheral Vascular Device Market Will Generate $35 Million in 2009.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters